Scientific Publication

0

New publication for Utipro® Plus

We are pleased to announce the publication of a case series referring about the benefits of Utipro® Plus in some challenging cases of urinary infections. In this new publication, that is the result of a fruitful collaboration among KOLs of international relevance, the product has proved its usefulness as a non-pharmacological approach in recurrent UTIs, thus allowing a rational use of antibiotics.

Read more

“Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update”

Piqué N, Miñana-Galbis D, Machlab S. Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update. Ann Pediatr Child Health 2020; 8(6): 1194.

We are proud to announce the publication “Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update”. This article elaborates on how a friendlier use of ORS is possible by improving palatability and texture, as well as limiting the volume per dosing. As a result, treatment compliance and, subsequently, therapeutic success, are more likely than with standard ORS preparations.

Read more

We are proud to announce the publication of the clinical trial “Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children"

Santos J. et al. Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children.Expert Rev Gastroenterol Hepatol: 2020 Oct 19;1-7. doi: 10.1080/17474124.2021.1833715.

We are proud to announce the publication of the clinical trial “Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children.”. While Oral Rehydration (ORS) is the main treatment of acute diarrhea in children, the addition of specific antidiarrheals may speed up the reduction of symptoms. In this clinical trial, children receiving xyloglucan/gelose (vegetal ingredients of Xilaplus AF) on top of the ORS, had significantly fewer diarrheic episodes than those who received ORS alone. The improvement of symptoms in the group on Xyloglucan/gelose was evident from 6 hours after the first dose.

Read more

Let's meet in..

2021, Oct 05

Vitafoods

Read more

2022, Feb 01

EWMA

Read more